Last updated: May 20, 2025
Sponsor: Nadezhda Women's Health Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Heparin solution
Anti-adhesion barrier gel
Clinical Study ID
NCT05257213
3/11022022
Ages 25-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
female sex
indication for operative hysteroscopy including one or more of the following:
infertility,
irregular bleeding,
oligo-/amenorrhea,
Asherman syndrome,
G0-G3 fibroids,
dysmorphic uterus.
Exclusion
Exclusion Criteria:
ongoing pregnancy,
genital cancer,
pelvic inflammatory disease,
excessive uterine bleeding.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Heparin solution
Phase:
Study Start date:
February 14, 2022
Estimated Completion Date:
February 28, 2026
Study Description
Connect with a study center
Nadezhda Women's Health Hospital
Sofia, 1373
BulgariaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.